Since the discovery of insulin more than 100 years ago, treatment type 1 diabetes has evolved, especiallyin recent years, with remarkable advances in drugs and medical devices. Continuous glucose monitoring (CGM)is now widely used worldwide for glycemic control mellitus, concept time range was proposed as new metric using CGM beyond A1c. This indicates percentage inthe target (70–180 mg/dl) at ...